Clinical Characteristics and Outcomes in Patients With COVID-2019 and Leprosy.

The emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a highly infectious virus that causes coronavirus disease 2019 (COVID-19), has raised important questions about the target groups at risk of illness and/or death.1 COVID-19 mortality has been higher in men, older people, unassisted by health systems and those having non-communicable disease.1,2 However, information is still lacking on how COVID-19 can affect people with infectious disease. Herein, we described the clinical features and outcomes in patients with COVID-19 and leprosy in an endemic area in Brazil.